Unknown

Dataset Information

0

Identification of cetrimonium bromide and irinotecan as compounds with synthetic lethality against NDRG1 deficient prostate cancer cells.


ABSTRACT: The N-myc downstream regulated gene 1 (NDRG1) has been identified as a metastasis-suppressor gene in prostate cancer (PCa). Compounds targeting PCa cells deficient in NDRG1 could potentially decrease invasion/metastasis of PCa. A cell based screening strategy was employed to identify small molecules that selectively target NDRG1 deficient PCa cells. DU-145 PCa cells rendered deficient in NDRG1 expression by a lentiviral shRNA-mediated knockdown strategy were used in the primary screen. Compounds filtered from the primary screen were further validated through proliferation and clonogenic survival assays in parental and NDRG1 knockdown PCa cells. Screening of 3360 compounds revealed irinotecan and cetrimonium bromide (CTAB) as compounds that exhibited synthetic lethality against NDRG1 deficient PCa cells. A three-dimensional (3-D) invasion assay was utilized to test the ability of CTAB to inhibit invasion of DU-145 cells. CTAB was found to remarkably decrease invasion of DU-145 cells in collagen matrix. Our results suggest that CTAB and irinotecan could be further explored for their potential clinical benefit in patients with NDRG1 deficient PCa.

SUBMITTER: Wissing MD 

PROVIDER: S-EPMC3672184 | BioStudies | 2013-01-01T00:00:00Z

SECONDARY ACCESSION(S): NCT01162135

REPOSITORIES: biostudies

Similar Datasets

| S-EPMC7495929 | BioStudies
2018-01-01 | S-EPMC5980122 | BioStudies
2015-01-01 | S-EPMC4694976 | BioStudies
2017-01-01 | S-EPMC5536002 | BioStudies
2020-01-01 | S-EPMC7269778 | BioStudies
2017-01-01 | S-EPMC5467496 | BioStudies
2012-03-08 | GSE17317 | GEO
2019-01-01 | S-EPMC6852951 | BioStudies
2012-03-08 | E-GEOD-17317 | ArrayExpress
2016-01-01 | S-EPMC5119235 | BioStudies